Ruffer LLP’s Celgene Corp CELG Stock Holding History

Ruffer LLP’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-3,204,402	Closed	-$318M	–	98
2019 Q3	$318M	Buy	3,204,402 +88,241	+3%	+$8.38M	9.04%	2
2019 Q2	$288M	Buy	3,116,161 +713,687	+30%	+$67.8M	6.73%	3
2019 Q1	$227M	Buy	+2,402,474	New	+$210M	5.82%	7
2016 Q1	–	Sell	-4,381	Closed	-$525K	–	100
2015 Q4	$525K	Buy	+4,381	New	+$507K	0.02%	81

Other funds holding CELG

HCM

Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

WCG

Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

Ruffer LLP's CELG Position: Q4 2019 in Review

Ruffer LLP sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 3,204,402 shares — an estimated $318M sold.

Ruffer LLP first reported a position in CELG in Q4 2015 and held it in 4 quarters. The position peaked at $318M in Q3 2019. 3 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

Ruffer LLP reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
Ruffer LLP sold 3,204,402 Celgene Corp shares in Q4 2019, an estimated $318M.
Ruffer LLP first reported a position in Celgene Corp in Q4 2015 and held it in 4 quarters.
Ruffer LLP's Celgene Corp position peaked at $318M in Q3 2019.
3 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Ruffer LLP's 13F filing for Q4 2019, filed 6 Feb 2020.